Similar companies
Aldeyra Therapeutics X Follower Count
Aldeyra Therapeutics has 465 followers on X (formerly Twitter), down 1.1% over the past three months. Losing followers on X can indicate declining public interest or brand sentiment challenges.
With 465 followers, Aldeyra Therapeutics has a smaller X following than industry peers like Amgen (118,587) and Gilead Sciences (72,235).
How Aldeyra Therapeutics’s X Growth Feeds the ALDX AI Score
X follower trends are particularly relevant for companies with strong direct-to-consumer brands or high-profile leadership. A follower count is not a stock price on its own, but for consumer-facing companies a sustained shift in following can reflect changing brand momentum. AltIndex feeds Aldeyra Therapeutics’s X following into the ALDX AI Score as one of 25+ alternative data signals, weighed against hiring, web traffic, sentiment, and fundamentals.
For Aldeyra Therapeutics’s reach on other platforms, see Aldeyra Therapeutics Instagram followers, TikTok followers, YouTube subscribers, and Facebook followers.
For real-time conversation volume, see ALDX X mentions. For other demand signals, see web traffic, app downloads, and Google Trends.
Month over Month
| Sep 2026 | 467 | |
| Aug 2026 | 467 | |
| Jul 2026 | 470 | |
| Jun 2026 | 470 | |
| May 2026 | 471 | |
| Apr 2026 | 473 |
Aldeyra Therapeutics X (Twitter) Followers: Frequently Asked Questions
Aldeyra Therapeutics has 465 followers (465) on X (formerly Twitter), based on AltIndex’s tracking of the company’s official X account.
Aldeyra Therapeutics's X following is declining, down 1.1% over the past three months. View the trend chart above for the full history.
X follower trends are most telling for companies with strong direct-to-consumer brands or high-profile leadership. No single data point predicts a stock on its own, but a sustained change in Aldeyra Therapeutics's following can reflect shifting public interest. That is why AltIndex combines Aldeyra Therapeutics's X following with web traffic, hiring, sentiment, and 20+ other signals in its AI Score rather than reading any one signal in isolation.
Aldeyra Therapeutics underperforms its industry peers when it comes to X Followers, ranking dead last.
With fewer than 1,000 followers, Aldeyra Therapeutics' X account is in its growth phase, focusing on building its audience. This suggests a niche but potentially dedicated following, important for targeted engagement.
Sign up and get more insights on Aldeyra Therapeutics.
See Aldeyra Therapeutics’s complete x followers history
Sign up to unlock 1-year and all-time charts for ALDX, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREE
